Cargando…

Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia

Disorders of uric acid metabolism may be associated with pathological processes in many diseases, including diabetes mellitus, cardiovascular disease, and kidney disease. These diseases can further promote uric acid accumulation in the body, leading to a vicious cycle. Preliminary studies have prove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Hao-lu, Wu, Yi-wan, Bian, He-ge, Yang, Hui, Wang, Heng, Meng, Xiao-ming, Jin, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317579/ https://www.ncbi.nlm.nih.gov/pubmed/34335246 http://dx.doi.org/10.3389/fphar.2021.667753

Ejemplares similares

Washed microbiota transplantation reduces serum uric acid levels in patients with hyperuricaemia
por: Cai, Jin-Rong, et al.
Publicado: (2022)

Lycium barbarum polysaccharides protect mice from hyperuricaemia through promoting kidney excretion of uric acid and inhibiting liver xanthine oxidase
por: Yu, Xin, et al.
Publicado: (2020)

Anti-Gout Effects of the Medicinal Fungus Phellinus igniarius in Hyperuricaemia and Acute Gouty Arthritis Rat Models
por: Li, Hongxing, et al.
Publicado: (2022)

The Management of Hyperuricaemia
por: Bayliss, Richard, et al.
Publicado: (1984)

The Extract of Sonneratia apetala Leaves and Branches Ameliorates Hyperuricemia in Mice by Regulating Renal Uric Acid Transporters and Suppressing the Activation of the JAK/STAT Signaling Pathway
por: Wu, Yu-Lin, et al.
Publicado: (2021)

Corrigendum: The Extract of Sonneratia apetala Leaves and Branches Ameliorates Hyperuricemia in Mice by Regulating Renal Uric Acid Transporters and Suppressing the Activation of the JAK/STAT Signaling Pathway
por: Wu, Yu-Lin, et al.
Publicado: (2021)

Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality
por: Pérez Ruiz, Fernando, et al.
Publicado: (2019)

Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid
por: An, Meng-Fei, et al.
Publicado: (2023)

The Efficacy and Mechanism of Chinese Herbal Medicines in Lowering Serum Uric Acid Levels: A Systematic Review
por: Chen, Liqian, et al.
Publicado: (2021)

Effect of Eurycoma longifolia Stem Extract on Uric Acid Excretion in Hyperuricemia Mice
por: Bao, Ruixia, et al.
Publicado: (2019)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
por: Jiao, Xue-Feng, et al.
Publicado: (2023)

Favipiravir: Hyperuricaemia: case report
Publicado: (2021)

Association of Gut Microbiota and Biochemical Features in a Chinese Population With Renal Uric Acid Stone
por: Cao, Cheng, et al.
Publicado: (2022)

Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
por: Yu, Wei, et al.
Publicado: (2020)

Advances in the management of malignancy-associated hyperuricaemia.
por: Mahmoud, H. H., et al.
Publicado: (1998)

Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats
por: Wu, Le, et al.
Publicado: (2021)

Recent advances on uric acid transporters
por: Xu, Liuqing, et al.
Publicado: (2017)

Uric acid transporters BCRP and MRP4 involved in chickens uric acid excretion
por: Ding, Xuedong, et al.
Publicado: (2019)

SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
por: Chino, Yukihiro, et al.
Publicado: (2014)

Risk of dementia in gout and hyperuricaemia: a meta-analysis of cohort studies
por: Pan, Shu-Yue, et al.
Publicado: (2021)

Virtual screening and activity evaluation of human uric acid transporter 1 (hURAT1) inhibitors
por: Yang, Yacong, et al.
Publicado: (2023)

Hyperuricaemia and the metabolic syndrome in type 2 DM
por: Ogbera, Anthonia O, et al.
Publicado: (2010)

The first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia
por: Stewart, Sarah, et al.
Publicado: (2015)

Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
por: Jeyaruban, A., et al.
Publicado: (2021)

Gout and hyperuricaemia: modifiable cardiovascular risk factors?
por: Burnier, Michel
Publicado: (2023)

Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database
por: Zhao, Hui, et al.
Publicado: (2023)

Hyperthyroid and Hypothyroid Status Was Strongly Associated with Gout and Weakly Associated with Hyperuricaemia
por: See, Lai-Chu, et al.
Publicado: (2014)

Prevalence of hyperuricaemia in an Eastern Chinese population: a cross-sectional study
por: Han, Bing, et al.
Publicado: (2020)

Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan
por: Koto, Ruriko, et al.
Publicado: (2021)

Mangiferin Ameliorates Hyperuricemic Nephropathy Which Is Associated With Downregulation of AQP2 and Increased Urinary Uric Acid Excretion
por: Li, Xuechen, et al.
Publicado: (2020)

Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats
por: Yu, Yiran, et al.
Publicado: (2018)

Ca(2+)-Permeable Channels/Ca(2+) Signaling in the Regulation of Ileal Na(+)/Gln Co-Transport in Mice
por: Chu, Fenglan, et al.
Publicado: (2022)

Exercise serum regulates uric acid transporters in normal rat kidney cells
por: Jiang, Zhongye, et al.
Publicado: (2022)

Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room?
por: Abhishek, Abhishek, et al.
Publicado: (2017)

Hyperuricaemia in Cardiovascular Diseases: A Passive or an Active Player?
por: Katsiki, Niki, et al.
Publicado: (2015)

Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population
por: Timsans, Janis, et al.
Publicado: (2023)

Discovery of a Flexible Triazolylbutanoic Acid as a Highly Potent Uric Acid Transporter 1 (URAT1) Inhibitor
por: Tian, He, et al.
Publicado: (2016)

Sodium-Glucose Co-Transporter 2 Inhibitors Use Improves the Satisfaction With Anti-diabetic Agent Treatment: A Questionnaire-based Propensity Score-matched Study
por: Shi, Fang-Hong, et al.
Publicado: (2022)

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies
por: Wempe, Michael F, et al.
Publicado: (2012)

Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1
por: Cho, Sung Kweon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3qpbcf11vac5asgncdfpq9mo90